Cargando…
Hepatic GH Receptor Signaling Directly Suppresses Hepatic Steatosis and De Novo Lipogenesis, Independent of Changes in Plasma IGF1 and Insulin
A reduction in GH, as well as IGF1, is associated with non-alcoholic fatty liver disease (NAFLD). However, the relative contribution of changes in circulating GH and IGF1, to hepatic triglyceride accumulation (steatosis), remains to be clearly defined. To study the direct actions of GH on hepatocyte...
Autores principales: | Vazquez Borrego, Maria del Carmen, Moreno, Mercedes del Rio, Sarmento-Cabral, Andre, Mahmood, Mariyah, Subbaiah, Papasani V, Yakar, Shoshana, Cordoba-Chacon, Jose, Puchowicz, Michelle, Kineman, Rhonda D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089597/ http://dx.doi.org/10.1210/jendso/bvab048.095 |
Ejemplares similares
-
HepatocyteGHR/STAT5b Signaling Protects Against Liver Injury in NAFLD/NASH Mice Models Independent of Steatosis
por: del Río-Moreno, Mercedes, et al.
Publicado: (2021) -
SUN-LB52 The Protective Effects of Hepatocyte GH Receptor (GHR) Signaling Against Steatosis and Liver Injury Is Sexually Dimorphic and Autonomous of IGF1
por: Sarmento-Cabral, Andre, et al.
Publicado: (2020) -
FRI063 Effectiveness Of Liraglutide In Treating Obesity And Improving Hepatic Steatosis
por: Alfadda, Assim Abdulaziz, et al.
Publicado: (2023) -
SUN-106 Loss of Coordination in the Expression of Hepatic Lipase and Endoplasmic Reticulum Stress Genes in Steatosis
por: Havighorst, Amanda, et al.
Publicado: (2019) -
MON-LB108 Measurement Of Carotid Intima,hepatic Steatosis And Inflammatory Markers In Obese Children
por: Bazan, Maria Cristina
Publicado: (2020)